Baxter International (BAX) Other Non-Current Assets (2009 - 2026)
Baxter International's (BAX) quarterly Other Non-Current Assets came in at $692.0 million in Q1 2026, down 1.0% on a QoQ basis from $699.0 million in Q4 2025.
Baxter International (BAX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Other Non-Current Assets data on file, last reported at $692.0 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $692.0 million in Q1 2026; TTM through Mar 2026 was $692.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $699.0 million, down 7.42% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $692.0 million, down from $699.0 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for BAX reached as high as $2.9 billion in Q4 2023 and fell as low as $233.0 million in Q2 2023.
- Historically, Other Non-Current Assets has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2024.
- Across the five-year window, Other Non-Current Assets slumped 82.13% in 2023 and soared 388.84% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.1 billion in 2022, then jumped by 165.92% to $2.9 billion in 2023, then plunged by 74.4% to $755.0 million in 2024, then declined by 7.42% to $699.0 million in 2025, then dropped by 1.0% to $692.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $692.0 million in Q1 2026, $699.0 million in Q4 2025, and $755.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 692.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 692.00 Mn |
| Dec 31, 2025 | 699.00 Mn |
| Dec 31, 2024 | 755.00 Mn |
| Sep 30, 2024 | 2.89 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 1.15 Bn |
| Dec 31, 2023 | 2.95 Bn |
| Jun 30, 2023 | 233.00 Mn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.24 Bn |
| Jun 30, 2022 | 1.30 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.50 Bn |
| Jun 30, 2021 | 1.40 Bn |
| Mar 31, 2021 | 1.36 Bn |
| Dec 31, 2020 | 1.40 Bn |
| Sep 30, 2020 | 1.26 Bn |
| Jun 30, 2020 | 1.17 Bn |